{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:37:15Z","timestamp":1791250635107,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":3123,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1074\/jbc.m111.329078","type":"journal-article","created":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T06:20:54Z","timestamp":1328768454000},"page":"10344-10354","source":"Crossref","is-referenced-by-count":35,"title":["Proteasomal Inhibition Restores Biological Function of Mis-sense Mutated Dysferlin in Patient-derived Muscle Cells"],"prefix":"10.1016","volume":"287","author":[{"given":"Bilal A.","family":"Azakir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Di Fulvio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Kinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sinnreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M111.329078_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/1682","article-title":"Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy","volume":"20","author":"Liu","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M111.329078_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/1689","article-title":"A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B","volume":"20","author":"Bashir","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M111.329078_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0","article-title":"Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype","volume":"49","author":"Illa","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1074\/jbc.M111.329078_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2006.07.004","article-title":"Mutation impact on dysferlin inferred from database analysis and computer-based structural predictions","volume":"250","author":"Therrien","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1074\/jbc.M111.329078_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature01573","article-title":"Defective membrane repair in dysferlin-deficient muscular dystrophy","volume":"423","author":"Bansal","year":"2003","journal-title":"Nature"},{"key":"10.1074\/jbc.M111.329078_bib6","doi-asserted-by":"crossref","first-page":"17092","DOI":"10.1074\/jbc.M601885200","article-title":"Absence of dysferlin alters myogenin expression and delays human muscle differentiation in vitro","volume":"281","author":"de Luna","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.329078_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/excr.1999.4407","article-title":"Expression of the E6 and E7 genes of human papillomavirus (HPV16) extends the life span of human myoblasts","volume":"248","author":"Lochm\u00fcller","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1074\/jbc.M111.329078_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010122","article-title":"Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle","volume":"5","author":"Azakir","year":"2010","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M111.329078_bib9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/jnen\/63.10.1104","article-title":"In vivo and in vitro dysferlin expression in human muscle satellite cells","volume":"63","author":"De Luna","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1074\/jbc.M111.329078_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(80)90408-0","article-title":"The synthesis and distribution of desmin and vimentin during myogenesis in vitro","volume":"19","author":"Gard","year":"1980","journal-title":"Cell"},{"key":"10.1074\/jbc.M111.329078_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/humu.9355","article-title":"Dysferlin mutations in LGMD2B, Miyoshi Myopathy, and a typical dysferlinopathies","volume":"26","author":"Nguyen","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1074\/jbc.M111.329078_bib12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneur.64.8.1176","article-title":"Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes","volume":"64","author":"Nguyen","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1074\/jbc.M111.329078_bib13","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1002\/humu.20910","article-title":"Analysis of the DYSF mutational spectrum in a large cohort of patients","volume":"30","author":"Krahn","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1074\/jbc.M111.329078_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.clineuro.2009.05.001","article-title":"Novel DYSF mutations in Thai patients with distal myopathy","volume":"111","author":"Liewluck","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1074\/jbc.M111.329078_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1081\/CNV-120030218","article-title":"Development of the proteasome inhibitor Velcade (bortezomib)","volume":"22","author":"Adams","year":"2004","journal-title":"Cancer Invest."},{"key":"10.1074\/jbc.M111.329078_bib16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1517\/13543784.17.6.879","article-title":"The potential of proteasome inhibitors in cancer therapy","volume":"17","author":"Sterz","year":"2008","journal-title":"Expert Opin. Investig. Drugs."},{"key":"10.1074\/jbc.M111.329078_bib17","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1742-4658.2006.05181.x","article-title":"Protein-misfolding diseases and chaperone-based therapeutic approaches","volume":"273","author":"Chaudhuri","year":"2006","journal-title":"FEBS J."},{"key":"10.1074\/jbc.M111.329078_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nmd.2009.12.003","article-title":"Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation","volume":"20","author":"Belanto","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1074\/jbc.M111.329078_bib19","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-03-0781","article-title":"Approval summary for bortezomib for injection in the treatment of multiple myeloma","volume":"10","author":"Bross","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1074\/jbc.M111.329078_bib20","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"Hideshima","year":"2001","journal-title":"Cancer Res."},{"key":"10.1074\/jbc.M111.329078_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0092-8674(95)90240-6","article-title":"Degradation of CFTR by the ubiquitin-proteasome pathway","volume":"83","author":"Ward","year":"1995","journal-title":"Cell"},{"key":"10.1074\/jbc.M111.329078_bib22","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI24898","article-title":"Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening","volume":"115","author":"Pedemonte","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1074\/jbc.M111.329078_bib23","doi-asserted-by":"crossref","first-page":"37702","DOI":"10.1074\/jbc.M006657200","article-title":"Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation: treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3","volume":"275","author":"Galbiati","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.329078_bib24","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2353\/ajpath.2010.090468","article-title":"Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies","volume":"176","author":"Gazzerro","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1074\/jbc.M111.329078_bib25","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.4161\/cc.6.10.4182","article-title":"Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice","volume":"6","author":"Bonuccelli","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.M111.329078_bib26","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1212\/01.wnl.0000204358.89303.81","article-title":"Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy","volume":"66","author":"Sinnreich","year":"2006","journal-title":"Neurology"},{"key":"10.1074\/jbc.M111.329078_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/scitranslmed.3000951","article-title":"A naturally occuring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy","volume":"2","author":"Krahn","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1074\/jbc.M111.329078_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/humu.21160","article-title":"Efficient bypass of mutations in dysferlin-deficient patient cells by antisense-induced exon skipping","volume":"31","author":"Wein","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1074\/jbc.M111.329078_bib29","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ejhg.2010.4","article-title":"Therapeutic exon skipping for dysferlinopathies?","volume":"18","author":"Aartsma-Rus","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1074\/jbc.M111.329078_bib30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1074\/jbc.M111.329078_bib31","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"van Deutekom","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/jbc.M111.329078_bib32","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/hmg\/ddq065","article-title":"Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer","volume":"19","author":"Lostal","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M111.329078_bib33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1152\/japplphysiol.01366.2009","article-title":"Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression","volume":"109","author":"Wang","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"10.1074\/jbc.M111.329078_bib34","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1038\/cddis.2010.35","article-title":"Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy","volume":"1","author":"D\u00edaz-Manera","year":"2010","journal-title":"Cell Death Disease"},{"key":"10.1074\/jbc.M111.329078_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/13770","article-title":"Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B","volume":"23","author":"Bittner","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M111.329078_bib36","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/hmg\/ddh212","article-title":"Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency","volume":"13","author":"Ho","year":"2004","journal-title":"Hum. Mol. Genet."}],"updated-by":[{"DOI":"10.1074\/jbc.a111.329078","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:00:00Z","timestamp":1501200000000},"record-id":"7525"},{"DOI":"10.1074\/jbc.a111.329078","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:00:00Z","timestamp":1501200000000}}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582065445X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582065445X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M111.329078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T08:51:06Z","timestamp":1641372666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582065445X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S002192582065445X"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m111.329078","relation":{"erratum":[{"id-type":"doi","id":"10.1074\/jbc.A111.329078","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}